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Abstract (250 words) 
Objective 
To determine if oesophago-gastro-duodenoscopy (OGD) generates increased levels of aerosol in 
conscious patients and identify the source events. 
Design 
A prospective, environmental aerosol monitoring study, undertaken in an ultraclean environment, on 
patients undergoing OGD. Sampling was performed 20cm away from the patient’s mouth using an 
optical particle sizer. Aerosol levels during OGD were compared to tidal breathing and voluntary 
coughs within subject. 
Results 
Patients undergoing bariatric surgical assessment were recruited (mean BMI 44, mean age 40yrs, 
n=15). A low background particle concentration in theatres (3 L-1) enabled detection of aerosol 
generation by tidal breathing (mean particle concentration 118 L-1). Aerosol recording during OGD 
showed an average particle number concentration of 595 L-1 with a wide range (3 – 4,320 L-1). 
Bioaerosol generating events, namely coughing or burping, were common.  Coughing was evoked in 
60% of the endoscopies, with a greater peak concentration and a greater total number of sampled 
particles than the patient’s reference voluntary coughs (11,710 v 2320 L-1 and 780 v 191 particles, n=9, 
P=0.008). Endoscopies with coughs generated a higher level of aerosol than tidal breathing whereas 
those without coughs were not different to background. Burps also generated increased aerosol 
concentration, similar to those recorded during voluntary coughs. The insertion and removal of the 
endoscope was not aerosol generating unless a cough was triggered. 
Conclusion 
Coughing evoked during OGD is the main source of the increased aerosol levels and therefore OGD 
should be regarded as a procedure with high risk of producing respiratory aerosols.  OGD should be 
conducted with airborne personal protective equipment and appropriate precautions in those 





What is already known about this subject? 
Oesophago-gastro-duodenoscopy (OGD) is currently classified as an Aerosol Generating 
Procedure. Recent aerosol sampling studies have demonstrated increased particle concentration 
above background during OGD but not identified the source events. 
What are the new findings? 
An uneventful OGD (without coughing or burping) does not generate aerosol above that 
associated with tidal breathing. More specifically, insertion and removal of an endoscope for 
OGD does not generate an increase in aerosol concentration. However, the process of OGD 
frequently triggers coughs in conscious patients. Such OGD-evoked coughs generate higher 
aerosol concentration than volitional coughs and the resultant plumes of airborne particles are 
likely to be associated with an increased risk of transmission of respiratory pathogens. Our study 
puts the aerosol generated during endoscopy into a meaningful context of normal respiratory 
events and identifies the index risk events. 
How might it impact on clinical practice in the foreseeable future? 
OGD-evoked coughs are common. Therefore, OGD should be treated as having a high risk of 
aerosol generation and should be conducted with airborne personal protective equipment and 
appropriate precautions in those patients who are at risk of having COVID-19 or other respiratory 
pathogens.  Strategies to reduce coughing and eructation would reduce aerosol generation. 
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INTRODUCTION 
The Coronavirus-19 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-
2 (SARS-CoV-2), has led to dramatic and widespread changes in the way hospital medicine is practised. 
SARS-CoV-2 has the potential to be spread by three main routes: droplet, contact and airborne. The 
extent of airborne transmission of SARS-CoV-2 remains debated [1, 2, 3, 4] but is of increasing concern 
especially with the advent of new strains of the virus (e.g. B.1.1.7) that have increased transmissibility 
[5, 6]. Infectious respiratory aerosols are considered by the World Health Organisation as being 
composed of particles <5 micrometres in diameter [7] which remain in suspension in the air for many 
minutes or hours, potentially leading to distant transport of viral particles [8, 9]. Importantly, particles 
of this dimension are respirable, enabling deposition deep within the human respiratory tract leading 
to transmission of disease [8]. 
A number of medical interventions have been designated ‘aerosol generating procedures’ (AGPs). 
These AGPs are considered to carry the highest risk of airborne transmission of respiratory pathogens 
to healthcare workers. The interventions currently categorised as AGPs are based predominantly on 
epidemiological data from the 2003 SARS-COV-1 epidemic [10, 11]. The WHO list of AGPs has been 
adopted or adapted by many national healthcare organisations such as the Center for Disease Control 
and Prevention (CDC) [12] and Public Health England (PHE) [13].  Oesophago-gastro-duodenoscopy 
(OGD) is classified as an AGP and this designation has led to development of joint guidelines for safe 
endoscopy by the Gastroenterological societies in the UK[14], Europe [15] and USA [16]. 
Current national and international guidance recommends the use of airborne precaution personal 
protective equipment (PPE) when undertaking AGPs, which includes the use of respirators (e.g. FFP3 
or N95 masks). Other recommendations include performing AGPs in a closed space with good 
ventilation [17, 18] and allowing a sufficient ‘fallow’ interval such that aerosol may disperse after the 
procedure [19]. These precautions inevitably slow the turnover within an operating room or 
procedural suite, and the wearing of PPE may impact on the quality of care delivered due to  physical 
and communication difficulties. 
The categorisation of OGD as an AGP was not based on evidence demonstrating aerosol generation 
from this intervention, nor from being associated with an increased incidence of SARS-CoV-2 
transmission to healthcare workers conducting the procedures. Recent work directly measuring 
aerosol levels in the clinical environment has questioned the validity of inclusion of several procedures 
defined as ‘aerosol generating’ including tracheal intubation and extubation [20]; percutaneous 
tracheostomy [21]; and respiratory supportive treatments such as continuous positive airway pressure 
delivered via a face mask [22, 23, 24]. 
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Two recent proof-of-concept studies reported increased levels of aerosol measured during OGD and 
concluded that the procedure is an AGP [25, 26].  However, these studies have been unable to 
definitively identify the specific source event responsible for the aerosol generation (i.e. endoscope 
insertion / removal, coughing, deep breathing, gastrointestinal eructation or retching), nor were they 
able to place the findings in the context of the risk of aerosol generation by natural respiratory events 
(tidal breathing, coughing).  This is important as respiratory events such as coughing, speaking and 
breathing have been shown to generate measurable concentrations of aerosol [27, 28, 29, 30, 31]. To 
strengthen the evidence base underlying designation of AGPs, and the rationale for stringent airborne 
transmission-based precautions, it is essential to determine how much aerosol these procedures 
generate compared to natural respiratory events. We therefore quantitated the extent to which OGD, 
performed in conscious patients, generates aerosols and compared this to the aerosol generated by 





A prospective environmental sampling study was undertaken to measure the amount and size 
distribution of particles generated by conscious patients undergoing OGD in a UK hospital (North 
Bristol NHS Trust). Ethical approval was granted by the Greater Manchester REC committee 
(Reference: 20/NW/0393) as part of the AERATOR study (approved 18/09/2020).  The study is 
registered in the ISRCTN registry (ISRCT:N21447815) and granted Urgent Public Health status by the 
NIHR. Patients or the public were not involved in the design, or conduct, or reporting, or dissemination 
plans of our research. 
Selection of patients 
Study participants were over 18 years of age and undergoing diagnostic OGD as part of a bariatric 
surgical assessment. The indication for endoscopy was in line with the International Federation for the 
Surgery of Obesity and Metabolic Disorders (IFSO) Position Statement [32] which recommends 
consideration of OGD in patients without upper gastrointestinal symptoms prior to bariatric and 
metabolic surgery procedures. All patients had self-isolated for two weeks, had a negative SARS-CoV-
2 polymerase chain reaction test in the 72-hours before admission and gave written informed consent 
before entry to the study. 
Study conduct 
The objective of the study was to measure aerosol generated during the routine conduct of OGD.  To 
sensitively detect aerosols generated by either natural respiratory events or AGPs, the measurements 
must be undertaken in an environment where background airborne particle concentrations are very 
low. Therefore, recordings were undertaken in operating theatres with an ultra-clean ventilation 
system (EXFLOW 32; Howorth Air Technology, Farnworth, UK) with high efficiency particulate air 
(HEPA) filtration. The ultra-clean ventilation system (UCV) provides an environment which is both 
ultra-clean and highly ventilated. We have previously demonstrated that the UCV ensures a very low 
background particle concentration, enabling detection of aerosols generated by natural respiratory 
events and AGPs [20, 21, 31, 33].  
The UCV was placed in standby mode during recordings to minimise any effect the high air change 
rate may have on particle detection [33].  When fully operational, the UCV system generates a ‘surgical 
canopy’ of clean air, which is directed vertically downward over the operating table within a perimeter 
delineated by markings on the floor. The air handling unit runs at 50Hz to generate this ultra-clean 
zone which results in 500-600 air changes per hour within the perimeter. When the system is placed 
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in ‘standby mode’ the frequency of the inverter in the air handling unit is reduced to 25Hz and the 
‘surgical canopy’ of constrained laminar airflow is lost, this reduces the number of air changes to 25 
per hour (equivalent to a standard operating theatre).  The air flow velocity is 0.25m.s-1 at 1m above 
the ground. This still provides an ultraclean environment (minimising interference from background 
aerosol) [33] but without the high number of air changes, ensuring any findings are generalisable to 
more typical operating theatre settings. 
All healthcare workers, and members of the investigating team, wore contact and droplet precaution 
PPE in line with both trust, and national policy. The number of staff in the room and their movement 
were kept to a minimum throughout the study to minimise extrinsic and artefactual aerosol 
generation. 
A portable Optical Particle Sizer (OPS, TSI Incorporated, model 3330, Shoreview, NM, USA) was used. 
The OPS samples air at 1 L.min-1 and detects particles by laser optical scattering, reporting the particle 
number concentration and size distribution within the range 300 nm to 10 µm diameter, with a 
sampling bin width of 1 s.  All air sampled was via a 3D printed funnel (formed of Polylactic acid on a 
RAISE3D Pro2 Printer, 3DGBIRE, Chorley, UK) with a maximum diameter of 150 mm, cone height of 90 
mm with a 10-mm exit port. Conductive silicone sampling tubing (3001788, TSI, 1m length, 4.8 mm 
internal diameter) connected the funnel to the OPS. The silicone tube had an internal volume of 72.5 
ml giving a transit lag between the funnel and the particle sizer (with a flow of 1 L.min1) of 4.3 s which 
was taken into account in the time registration of measurements. In previous work, we have 
established that the transmission sampling loss of particles < 5 µm diameter with this set up is <10 % 
[31]. It should be noted that we cannot report the absolute number of particles generated, only the 
number sampled and detected, recognising that we do not sample all of the air from the activity into 
the OPS instrument. 
Reference aerosol generation was measured in each patient before endoscopy with the patient 
positioned supine on the operating table in the theatre. The sampling funnel was handheld by the 
investigator approximately 20cm in front and directed towards the patient’s face. The reference 
sequences consisted of one-minute quiet tidal breathing, followed by three maximal voluntary coughs 
at 30 second intervals, with tidal breathing in between. Background aerosol was then measured with 
the funnel at 1 metre distance, facing away from the patient (and any other staff) but still within the 
central area of the UCV system while the patient was prepared for the endoscopy as below. 
All patients had topical anaesthesia of their oropharynx with Lidocaine 10% (Xylocaine, 50 ml/500 
spray, AstraZeneca, Sweden). The OGD was performed in the left lateral position, with conscious 
sedation achieved with intravenous midazolam as necessary by the endoscopist, according to their 
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normal practice. A mouthguard was inserted prior to insertion of the endoscope (8.9mm GIF-H290 
Video Gastrointestinal Scope with EVIS X1 CV-1500 Video System; Olympus, Tokyo, Japan).  
Aerosol generation during endoscopy was measured with the sampling funnel, handheld 20 cm from 
the patient’s mouth. This enabled insertion of the endoscope between the funnel and the mouth. The 
aerosol generated during OGD was analysed for all periods between endoscope insertion through the 
mouthguard until endoscope removal. These periods were aggregated for those patients where more 
than one endoscope insertion was undertaken. Aerosol sampling commenced for reference 
recordings, undertaken prior to initial endoscope insertion, and was continuous until after final 
endoscope removal. All events of significance were timestamped (i.e. endoscope insertion, endoscope 
removal, coughs, burping).  Cough events (both voluntary and evoked during endoscopy) were 
averaged within subject and then aggregated across the whole group. 
Data were exported from the OPS, processed in the TSI Aerosol Instrument Manager software, and 
analysed in Origin Pro (Originlab, Northampton, MA, USA) and Prism v8 (Graphpad, San Diego, CA, 
USA). We report the sampled mean aerosol concentration as well as the peak concentration over 1 s 
sampling time, reported as mean (SD). We used paired or unpaired t-tests or Mann-Witney and 
Wilcoxon tests to conduct statistical comparisons as appropriate. The criterion for statistical 




Fifteen patients were recruited: fourteen were being assessed before bariatric surgery and one patient 
attended for assessment 2 years after gastric bypass surgery. There were two males and thirteen 
females with a mean BMI of 46 ± 9.3 kg/m2 and an average age of 42 years (range 21-75). Four patients 
requested and received additional conscious sedation with endoscopist-administered midazolam. 
Background sampling showed the air was very clean with a mean aerosol number concentrations, 
referred to below simply as the concentration, of 3.1 (3.7) particles.L-1 (corresponding to ~3 particles 
detected each minute of sampling). The patient’s tidal breathing, via the mouth, generated a mean 
particle concentration of 118 (97.2) L-1 and an average peak particle concentration of 540 (410) L-1 
(n=15 patients) (Figure 1). In nine patients a further minute of nasal breathing was recorded, this 
generated a mean particle concentration of 63.5 (72.0) L-1 and a peak particle concentration of 327 
(283) L-1 (n=9). Nasal breathing produced a lower aerosol concentration than mouth breathing 
(P=0.008, Wilcoxon).  
[Figure 1] 
The expulsive phase of a cough typically lasts less than 1 second [34], and the aerosol concentration 
rises rapidly to a sharp peak, with a subsequent decay as the remaining aerosol reaches the sampling 
funnel, dissipates and becomes diluted by clean background air (Figure 2). The reference voluntary 
coughs for the 15 patients each generated an aerosol concentration profile clearly detectable above 
the baseline with a mean peak concentration of 2330 (2120) L-1, an average total number of particles 
detected per cough of 192 (183) and mean duration of 19.8 (5.8) s. 
[Figure 2] 
The mean aerosol particle concentration measured during endoscopy was 595 (1110) L-1 (n=15, Figure 
1a) and the average duration of endoscopy was 222 s (range 129 – 457s).  This aerosol concentration 
was well above background levels but was not significantly higher than the level of aerosol measured 
during mouth breathing (vs 118 L-1, P=0.17, Wilcoxon test).  We noted that there was a very large 
range of average aerosol concentrations between endoscopy sessions from 3 L-1 (indistinguishable 
from background – see figure 3a) to 4320 L-1 (figure 3b).  Coughs were frequently evoked during the 
endoscopy (figure 3b, 9/15 subjects were observed to cough – with a median of 4 coughs [range 1-
10]).  Likewise, burps were induced during some procedures (figure 2b, 4/15 subjects burped – median 
of 2 burps per endoscopy [range 1-4]). 
The OGD-evoked coughs generated high concentrations of aerosol (Figure 2a & 3b) with a mean peak 
concentration of 11,710 (13,700) L-1, and total number of particles detected per cough of 780 (1010). 
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The total number of particles from evoked coughs was significantly greater than the volitional coughs 
recorded from the same patients (780 vs 191, n=9, P=0.008, Wilcoxon) and the peak mass 
concentration was higher (4.51 vs 0.54 µg/m3, P=0.008, Wilcoxon). Similarly, the peak particle 
concentration was greater for evoked versus volitional coughs (11,710 v 2320 L-1, P=0.008 Wilcoxon). 
The profile of the particle concentration generated by evoked coughs remained detectable above the 
baseline for a mean duration of 14.5 (4.8) s. Analysis of the size distribution of these evoked coughs 
showed them to have a similar profile to volitional coughs, reported as number concentration 
distribution across the size-resolved bins of the OPS, but with an increase in the total numbers of 
particles in each size bin (Figure 4).  
[Figure 3] 
Burps observed during OGD procedures generated a mean peak concentration of 3060 (3830) L-1 and 
a total number of particles detected per burp of 205 (280). There was no significant difference 
between the peak particle concentration or total number of detected particles of a voluntary cough 
and burp by the same patient.  Analysis of the particle size distribution of these evoked burps showed 
them to have a different profile to coughs, with a decrease in the total numbers of particles in the size 
range between 0.5 and 1.5µm (Figure 4). 
As an evoked cough or a burp had a large effect on the particle concentration, our subsequent analysis 
split the patients into those who had such “bioaerosol generating events” (BGEs) versus those who 
did not.  The mean aerosol number concentration sampled during the eleven endoscopies with BGEs 
was higher than that recorded during the four endoscopies where no cough or burp was triggered 
(808 (1240) L-1 vs 10.0 (7.2) L-1, Mann-Whitney test, P=0.0015). When these transient and discrete 
coughing or burping events were excluded from the analysis, the mean particle concentration during 
the rest of the endoscopy was 31.4 (33.9) L-1 identifying the discrete BGEs as being responsible for the 
overall elevation in aerosol during the procedure. 
[Figure 4] 
A focussed analysis of aerosol concentration fluctuations during a 30 s sampling window surrounding 
endoscope insertion (n=12) and removal (n=11) (starting 10 s prior to insertion or removal), excluding 
those which triggered BGEs, showed a low concentration of aerosol which was not significantly 
different to background and was less than both tidal breathing and voluntary coughs (Figure 5).  No 
other significant aerosol generating events were identified during the conduct of the OGDs. 
[Figure 5]  
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DISCUSSION 
We have measured aerosol generation in patients undergoing OGD. In the patients who coughed 
during the procedure (60%), very high particle concentrations were detected - around five-fold higher 
than those seen during volitional coughs. This suggests that OGD meets the criterion for being a high 
risk procedure for generating aerosol in those patients in whom endoscopy evokes a cough. This is 
consistent with the findings of recent studies which also concluded that OGD was associated with 
increased aerosol generation [25, 26].  However, we specifically identify that evoked coughs and 
belches are the index risk events rather than the insertion and removal of the endoscope from the 
oesophagus. 
Conducting aerosol sampling during OGD in a HEPA-filtered ultraclean environment provides an 
optimal setting for detecting aerosols due to the extremely low background concentration. Sampling 
in an adjacent operating theatre (non UCV) revealed a baseline particle content of 16,000 particles L-
1 (compared to 3 L-1) [33]. Sampling in such a theatre would mean the aerosol detected in this study 
(for example associated with tidal breathing) would be impossible to detect over background ‘noise’. 
We note that a previous study of OGD aerosol generation also found high background counts (25-
40,000 particles per Cubic Foot equating to ~900-1400 particles L-1) in their procedure room, which 
had a standard ventilation system [25].  This would preclude detection of the aerosol generated by 
breathing or even a volitional cough over the background particle count (likely mostly inorganic ‘dust’ 
rather than bioaerosol).  Importantly, the high temporal resolution (1Hz measurements of airborne 
particles) in combination with the low background aerosol concentration enables the definitive 
attribution of specific respiratory or procedural events as being the source of the aerosol (rather than 
attempting to make the link by inference when using a minute by minute analysis [26]).  
A novel aspect of our study design is using each patient’s own respiratory events as a comparator.  
This puts the aerosol measurements made during endoscopy into a meaningful biological context of 
normal respiratory events.  This approach also reduces the impact of between-subject variation and 
so increases the power to detect significant changes even within a relatively small sample size.  We 
used tidal breathing as a lower reference for natural aerosol generation and could reliably detect this 
aerosol concentration above background (the first time such a measure has been possible in a study 
of patients). For the patients who did not cough during the procedure lower concentrations were 
detected than during coughing or even normal tidal breathing. This may be due to the presence of the 
bite guard, attenuation by the endoscope itself or the endoscopist’s hands, or due to shallow / nasal 
breathing during the procedure. 
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The sampling method used in our study is appropriate to detect aerosol particles generated from the 
respiratory system which are generally in the range of 10 nm to 20 µm, with a large predominance in 
the sub-micron range [29]; we do not detect droplets larger than 20 µm and can make no statement 
about their presence or absence from these procedures. We set out to study aerosol levels close to 
the source of generation.  By sampling close to the patient (20cm) we achieve an accurate measure of 
exposure risk for the endoscopist and assistant who will be within the near vicinity of the patient 
(within 1m) so any emitted plumes of aerosol are highly relevant to their risk of transmission.  The 
WHO have defined aerosols as being composed of particles <5µm in size but recently, such a strict 
delineation in size has been questioned: moist exhaled droplets smaller than 100 µm can decrease 
considerably in size, showing similar aerodynamic behaviour to aerosol such that they can present a 
transmission risk over many metres [35].  This is relevant particularly when considering the dispersal 
of particles within the room which is currently not directly experimentally quantifiable for respiratory 
aerosols given the relatively low concentrations of particles and the enormous degree of dilution that 
occurs with dispersal even in a room with standard ventilation.  We believe that the primary risk to 
the endoscopy team is from the close-quarters exposure to respiratory aerosol near the site of 
generation (the patient) but the issue of potential particle persistence and dispersal within the room 
as a route of transmission may also be a factor that merits further investigation (for review see [36]). 
Respiratory aerosols are considered to be well represented by a bimodal distribution, with mean 
aerodynamic diameters of the two modes in the range 800 to 1500 nm; the smaller mode is considered 
to arise in the lower respiratory tract, the bronchioles, and the larger is assigned as the laryngeal mode 
[29]. The OPS cannot intrinsically differentiate between respiratory and non-respiratory aerosols, but 
by timestamping events, minimising movement of the investigator, sampling close to the patient and 
using a funnel to directionally focus on sources originating from the patient we reduced the risk of 
artefactual particle detection or detection of aerosol from staff in the room.  We did not take any 
specific precautions such as limiting staff movement or altering their routine care during the conduct 
of these endoscopies and so our results are characteristic of aerosol generated during typical clinical 
practice.  The size distribution of the particles detected during the study was typical of respiratory 
aerosols; it formed a log-normal distribution of particles with the peak lying in the submicron size 
range [20, 29, 30] and had a similar profile for both voluntary and procedure-evoked coughs [20].  This 
suggests the mechanism generating the aerosol is similar in both cases and provides a characteristic 
fingerprint distinguishing respiratory aerosols from other potential particle sources (ie from fabric / 
bedding dust released by movement of staff and patient).   
The increased number of particles produced by OGD-evoked coughs, above those produced by a 
volitional cough, may relate either to a more forceful reflexively-generated protective cough, to the 
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presence of fluid in the oropharynx associated with the endoscopy, or to partial occlusion of the 
oropharynx during endoscopy reducing the diameter of the airway and increasing the amount of 
turbulent flow. Interestingly burps (eructations) also produced measurable aerosol but this had a 
different size distribution to coughs (with an order of magnitude fewer particles in the size range from 
0.5-1.5µm) reflecting the different site of origin of the aerosol.  However, although the gastric source 
of the BGE is unlikely to represent a reservoir for SARS-CoV-2 (unlike the lungs), the passage of 
turbulent gas flow over the oro- and naso-pharyngeal membranes still could result in generation of 
virus containing aerosol so should not be discounted as a risk. 
Our study was not designed to look at the potential mitigating effect of using sedation to reduce 
coughing. Midazolam was administered to four patients for conscious sedation at patient request.  All 
of the patients receiving midazolam coughed compared to 50% of the remainder.  A subsequent 
exploratory study of the incidence of coughing in patients having upper GI endoscopy in our institution 
showed similar findings with 67% (n=8/12) coughing with midazolam sedation and 40% without 
(n=4/10). This fits with the known lack of antitussive properties of benzodiazepines which tend to 
preserve airway reflexes (generally considered a safety advantage for endoscopy in reducing the 
incidence of aspiration and hypoxia).  Likewise, both of the previous studies of aerosol generation 
during endoscopy [25, 26] found no association with either the presence or quantity of sedation on 
aerosol generation (both with midazolam).  A randomised controlled study would be needed to 
answer the question as to whether conscious sedation can be used to reduce aerosol generation 
during endoscopy.  However, we also note that this would be a difficult trial to translate into change 
in guidelines as even a large reduction in the incidence of coughing (of say 50% as has been noted for 
combinations of midazolam and opiate [37, 38]) could not exclude the possibility that any individual 
patient would cough or burp and hence airborne PPE would still be needed.  This would also have to 
be balanced against the possible detrimental effect of suppression of protective airway reflexes which 
could increase the risk of hypoxia. 
There are several limitations to our study. Our sample size was relatively small, and 14 out of the 15 
participants had a BMI > 40 kg.m-2. It is possible that these patients with higher BMI may have 
generated more aerosol than leaner patients (as was suggested by the study of Sagami and colleagues 
[26], but this effect is likely to apply both for the baseline cough measurements and during endoscopy 
and so is controlled for in our study design looking at relative levels of airborne particles. It is not 
possible to extrapolate our findings to patients with active respiratory disease or COVID-19 infection 
as all participants were screened for COVID-19 and had no acute illness.  Our study cannot be used to 
determine the risk of COVID-19 transmission during endoscopy where the risk status of the patient 
(i.e. the likelihood of having COVID) is the major determinant. Our sampling methodology does not 
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detect aerosols smaller than 300 nm (approximately three times the diameter of the SARS-CoV-2 virus) 
however, respiratory particles less than 300 nm in diameter are extremely unlikely to carry viable 
virions unless the patient’s viral titre is extremely high. This lower size limit excludes aerosols of sub-
virus size which cannot contain the virus [39] but are always present in any environment at the highest 
concentration and number – so our sampling method reduces this irrelevant ‘noise’ signal. Similarly, 
aerosols greater than 10 µm are not detected using our techniques. However, particles larger than 5 
µm are classified as droplets and protection is afforded by droplet precaution PPE (ie fluid resistant 
surgical facemasks). 
Our findings are clinically relevant, particularly in the context of the COVID pandemic. Performing an 
OGD may unpredictably trigger coughing whenever the oropharynx is instrumented, and such OGD-
evoked coughs generate more aerosol than either breathing or volitional coughs. Based on our 
observations, OGD should continue to be designated an aerosol generating procedure in conscious 
patients.  Therefore, airborne protection PPE including a FFP3/N95 facemask and eye protection 
should be used in the care of any patient known or suspected to have COVID-19.  These precautions 
will likely have to continue while SARS-CoV-2 is still in circulation in the community and beyond for 
the management of any patients with respiratory pathogens. We also note there is currently an 
absence of epidemiological evidence demonstrating that OGD is associated with an increased risk of 
COVID transmission, but this may reflect the widespread adoption of airborne PPE and precautions by 
endoscopists and endoscopy staff.  Given the increased risk of aerosol generation we suggest that 
upper GI endoscopy should be conducted in an environment with a high level of air changes and 
carefully designed air flows to ensure rapid clearance and dispersal of aerosol [19]. We find no 
evidence for any other sources of increased aerosol generation during the OGD and therefore if a 
patient does not cough or belch during the OGD then consideration may be given to decreasing the 
time interval for air changes in the room between cases.  In addition, strategies to reduce the incidence 
of coughing and eructation should be explored as a means to decrease the risk of aerosol generation.  
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Figure 1  
 
Figure 1. a) Mean particle concentrations and b) peak particle concentrations generated during the 




Figure 2  
 
Figure 2  Mean particle concentration sampled during reference voluntary coughs (n=15 patients) 
overlaid with those for coughs evoked during OGD (n=9 patients) and burps observed during OGD 




Figure 3  
 
 
Figure 3 Continuous time series of aerosol detected during respiratory manoeuvres (tidal breathing 
and voluntary coughs) followed after a period of background monitoring by OGD 
a. Uneventful OGD without any significant aerosol generation. 
b. A more challenging endoscopy requiring multiple attempts at scope insertion which triggered 





Figure 4 (a) Particle size distribution of the events. dN/dlog(DP) is the concentration sampled within 
each bin normalised by the logarithm of the bin width. The error bars represent the standard error 
of the mean. (b) The size distribution of the average aerosol concentration generated by each 




Figure 5  
 
 
Figure 5 Profile of aerosol concentration detected during endoscope (a) insertion (n=12) (b) removal 
(n=11).  A low mean concentration of aerosol was detected in the 30 second time period around 
endoscope insertion (10.3 (9.5) particles.L-1) and removal (15.1 (12.4) particles.L-1) where the 
concentrations were not significantly different to background.  Note endoscope insertions (n=3) and 
removals (n=4) that immediately triggered coughing or burping (i.e. during this sampling window) 
were excluded from the pooled analysis. 
 
 
 
 
